Novack Jeffrey Adam's Form 4 filing
CareDx, Inc. (CDNA) · filed Feb 4, 2026
- Accession no.
- 0002019976-26-000001
- Filed
- Feb 4, 2026
- Trade date
- Feb 2-3, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 5 non-derivative transactions. Open-market sales total $91.3K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Novack Jeffrey AdamCIK 0002019976 | Officer (Secretary and General Counsel) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 2, 2026 | Common Stock | AGrant or awardAcquired | +33,000 | $0.00 | $0 | 130,925 | Direct | |
| Feb 2, 2026 | Common Stock | AGrant or awardAcquired | +4,342 | $0.00 | $0 | 135,267 | Direct | |
| Feb 2, 2026 | Common Stock | FTax withholdingDisposed | −2,492 | $20.42 | −$50,886.64 | 132,775 | Direct | |
| Feb 2, 2026 | Common Stock | FTax withholdingDisposed | −2,970 | $20.42 | −$60,647.4 | 129,805 | Direct | |
| Feb 3, 2026 | Common Stock | SSaleDisposed | −4,441 | $20.56 | −$91,306.96 | 125,364 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.